The trademark Dizal was filed by Dizal (Jiangsu) Pharmaceutical Co., Ltd., a corporation established under the laws of the People's Republic of China (the "Applicant"). The application was published for oppositions on January 24, 2023, and received one opposition filed on April 24, 2023 by ITALFARMACO, S.A. on Likelihood of confusion. the opponent was represented by ISERN PATENTES Y MARCAS, S.L. and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued April 24, 2023
The application was filed in English, and English was also language of all opposition proceedings (French was selected as the second language).
Goods And Services
The mark was filed in class 5 with following description of goods:
Anti-cancer preparations
Biological preparations for the treatment of cancer
Chemical reagents for medical purposes
Pharmaceutical preparations for the treatment of immune system related diseases and disorders
Pharmaceutical preparations for treating malignant Tumors
Pharmaceutical preparations for use in chemotherapy
Pharmaceutical preparations for suppressing tumors
Pharmaceutical products for the treatment of cancer
Pharmaceutical preparations and substances for the prevention of cancer
Elixirs (pharmaceutical preparations)
All the aforesaid products will be exclusively used for the treatment of cancer and malignant tumors.